As the Iran war drags on, Israeli solidarity comes under strain

Key event: Iran launched one of its heaviest barrages against Israel hours after Netanyahu’s wartime address, five weeks into the US-Israeli conflict. INSS polling shows belief Iran will collapse or be significantly weakened fell from ~70% to 43.5%; confidence in damaging Iran’s nuclear program dropped from 62% to 48% and in crippling its missile arsenal from 73% to 57%. Domestic fractures widened after passage of a 2026 budget favoring ultra-Orthodox allies, a divisive conscription bill despite a reported 15,000-soldier shortfall, and a death-penalty law — moves that raise the risk of international backlash/sanctions that could harm the economy. Netanyahu’s continued pardon push, including reported US presidential intervention, adds legal and political uncertainty.

Analysis

Political fragmentation at a time of sustained multi-front military pressure creates a structural volatility regime for Israeli assets: expect higher sovereign spread volatility, periodic equity drawdowns tied to headlines, and episodic FX pressure on the shekel. Market participants should price in persistent two- to six-week windows of elevated risk following major domestic legislative moves or battlefield setbacks, rather than one-off shocks.

A near-term second-order beneficiary is the global defence supply chain — not just prime contractors but niche munition, ISR, and drone component suppliers with 12–24 month revenue visibility. Procurement cycles will be lumpy: expect order flow to backload into FY+1 as manpower constraints force capex for force-multipliers, creating a multi-quarter revenue tail for suppliers with certificated platforms and mature production lines.

Diplomatic blowback risk (sanctions, research/tech decoupling) is non-linear: modest reputational hits compress R&D partnerships and equity multiples, but credible sanctions or funding cut-offs would materially reduce foreign direct investment and thin Israel’s VC exit market over 12–36 months. The single biggest counterbalance is external political cover from a powerful ally — if it arrives, markets can snap back quickly; absent that, expect protracted rerating of country risk and risk-off flows into safe-haven assets.

Key Decisions for Investors

• Long LMT or RTX (6–18 months): overweight prime defense contractors by 3–5% portfolio weight to capture expected 12–24 month procurement tail from multi-front conflict. Risk: geopolitical de-escalation or budget cuts; reward: 20–35% upside if order book growth materializes.
• Pair trade — long LMT (or NOC) / short EIS (iShares MSCI Israel ETF) (3–9 months): size pair 1–1 to hedge beta. Rationale: capture defense procurement upside while shorting domestic political/sanctions rerating. Risk: rapid political stabilization; target asymmetry 2:1 reward:risk (15–30% potential vs 7–15% downside).
• Tactical hedge — long GLD (or 3–6 month GLD call spread) (0–6 months): allocate 1–2% as portfolio insurance against headline-driven equity drawdowns and FX stress. Risk: higher real rates compress gold; reward: outsized protection during risk-off spikes.
• Short EIS outright (3–6 months) or buy puts if available: underweight Israeli equity exposure ahead of possible sanctions/tech decoupling and weaker FDI flows. Risk: over-penalization if diplomatic support prevents sanctions; reward: 10–25% downside in stressed scenarios.